Les syndromes myélodysplasiques = Myelodysplastic syndromesBEYNE-RAUZY, O.La Revue de médecine interne (Paris). 2012, Vol 33, issn 0248-8663, A21-A23, HSConference Paper

Actualités dans les syndromes myélodysplasiquesFENAUX, P.La Revue de médecine interne (Paris). 2014, Vol 35, Num JUN, issn 0248-8663, A16-A17, HSConference Paper

Myelodysplastic syndromesADES, Lionel; ITZYKSON, Raphael; FENAUX, Pierre et al.Lancet (British edition). 2014, Vol 383, Num 9936, pp 2239-2252, issn 0140-6736, 14 p.Article

Nuclear PI-PLC β1 and Myelodysplastic Syndromes: From Bench to ClinicsMONGIORGI, Sara; FOLLO, Matilde Y; CLISSA, Cristina et al.Current Topics in Microbiology and Immunology. 2012, Vol 362, pp 235-245, issn 0070-217X, 11 p.Article

The Myelodysplastic SyndromesNGUYEN, Phuong L.Hematology/oncology clinics of North America. 2009, Vol 23, Num 4, issn 0889-8588, v, 675-691 [13 p.]Article

Overview of Myelodysplastic SyndromesBERIS, Photis; GEORGIOU, George.Seminars in hematology. 2012, Vol 49, Num 4, pp 287-294, issn 0037-1963, 8 p.Article

Hypomethylating Agents and Other Novel Strategies in Myelodysplastic SyndromesGARCIA-MANERO, Guillermo; FENAUX, Pierre.Journal of clinical oncology. 2011, Vol 29, Num 5, pp 516-523, issn 0732-183X, 8 p.Article

LES SYNDROMES MYÉLODYSPLASIQUESBEYNE-RAUZY, O.Age & nutrition (Paris). 2010, Vol 21, Num 1, pp 16-20, issn 1158-0259, 5 p.Article

Acquired mutations in TET2 are common in myelodysplastic syndromesLANGEMEIJER, Saskia M. C; KUIPER, Roland P; KAMPING, Eveline J et al.Nature genetics. 2009, Vol 41, Num 7, pp 838-842, issn 1061-4036, 5 p.Article

Hypocellular MyelodysplasiaSLOAND, Elaine M.Hematology/oncology clinics of North America. 2009, Vol 23, Num 2, issn 0889-8588, x, 347-360 [14 p.]Article

Fièvre prolongée au cours d'un syndrome 5q― révélant une transformation blastique extramédullaire = Extramedullary blastic transformation revealed by a prolonged fever during the course of a 5q― syndromeCHEHENSSE, C; BRAUN, T; FAIN, O et al.La Revue de médecine interne (Paris). 2009, Vol 30, Num 10, pp 886-889, issn 0248-8663, 4 p.Article

Nouveaux outils et traitements pour les syndromes myélodysplasiques = News tools and new treatments in myelodysplastic syndromesCLUZEAU, T; FENAUX, P.La Revue de médecine interne (Paris). 2013, Vol 34, Num 3, pp 159-167, issn 0248-8663, 9 p.Article

Thrombopénie d'origine centrale ou périphérique ? Un diagnostic différentiel souvent difficile entre purpura thrombopénique idiopathique et syndromes myélodysplasiques = Thrombocytopenia relative to idiopathic thrombocytopenic purpura or myelodysplastic syndromes : a frequent diagnostic issueBEYNE-RAUZY, O.La Revue de médecine interne (Paris). 2008, Vol 29, pp 89-93, issn 0248-8663, 5 p., HS1Conference Paper

Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromesGRAUBERT, Timothy A; DONG SHEN; MCLELLAN, Michael D et al.Nature genetics. 2012, Vol 44, Num 1, pp 53-57, issn 1061-4036, 5 p.Article

Occurrence of myelodysplastic syndrome in 2 patients with reticular dysgenesisLAGRESLE-PEYROU, Chantal; NEVEN, Bénédicte; ASNAFI, Vahid et al.Journal of allergy and clinical immunology. 2011, Vol 128, Num 1, pp 230-232, issn 0091-6749, 3 p.Article

Hematopoietic Growth Factors in Myelodysplastic SyndromesSTEENSMA, David P.Seminars in oncology. 2011, Vol 38, Num 5, pp 635-647, issn 0093-7754, 13 p.Article

Molecular Biology of Myelodysplastic SyndromesSHIH, Alan H; LEVINE, Ross L.Seminars in oncology. 2011, Vol 38, Num 5, pp 613-620, issn 0093-7754, 8 p.Article

Targeting Immune Dysregulation in Myelodysplastic SyndromesOLNES, Matthew J; SLOAND, Elaine M.JAMA, the journal of the American Medical Association. 2011, Vol 305, Num 8, pp 814-819, issn 0098-7484, 6 p.Article

Les syndromes myélodysplasiques : Syndromes myélodysplasiques = Myelodysplastic syndromes : Myelodysplatic syndromesSOLARY, Eric; FONTENAY, Michaëla.La Revue du praticien (Paris). 2010, Vol 60, Num 10, issn 0035-2640, 1408-1412 [3 p.]Article

Lenalidomide for Treatment of Myelodysplastic Syndromes: Current Status and Future DirectionsKOMROKJI, Rami S; LIST, Alan F.Hematology/oncology clinics of North America. 2010, Vol 24, Num 2, issn 0889-8588, viii-ix, 377-388 [13 p.]Article

Novel Therapies for Myelodysplastic SyndromesSTEENSMA, David P.Hematology/oncology clinics of North America. 2010, Vol 24, Num 2, issn 0889-8588, ix-x, 423-441 [21 p.]Article

Cytogénétique des syndromes myélodysplasiques et apport des techniques pangénomiquesWEMEAU, Mathieu; NIBOUREL, Olivier; LAÏ, Jean-Luc et al.Hématologie (Montrouge). 2010, Vol 16, pp 8-11, issn 1264-7527, 4 p., SUP3Conference Paper

The Role of the Immune System in Myelodysplasia : Implications for TherapySLOAND, Elaine M; REZVANI, Katayoun.Seminars in hematology. 2008, Vol 45, Num 1, pp 39-48, issn 0037-1963, 10 p.Article

Utilisation du lénalidomide dans les syndromes myélodysplasiques del(5q)ADES, L.Correspondances en onco-hématologie. 2014, Vol 9, Num 2, pp 76-80, issn 1954-4820, 5 p.Article

ATM polymorphism is associated with low risk myelodysplastic syndromeLOPES RIBEIRO, Howard; DE OLIVEIRA, Roberta Taiane Germano.DNA repair. 2013, Vol 12, Num 2, pp 87-89, issn 1568-7864, 3 p.Article